NEJM Interviews
Un pódcast de NEJM Group - Miercoles
864 Episodo
-
NEJM Interview: Dr. Marshall Chin on gaps and inequities in the health care system’s approach to managing chronic diseases.
Publicado: 27/10/2021 -
A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children
Publicado: 27/10/2021 -
A New Look at Covid-19 Vaccine Boosters
Publicado: 20/10/2021 -
NEJM Interview: Dr. Sasha Mallett on parenting during the Covid-19 pandemic as a person at high risk for infection and related harm.
Publicado: 20/10/2021 -
NEJM Interview: Prof. R. Alta Charo on a law that allows members of the public to file suit to stop abortions in Texas.
Publicado: 13/10/2021 -
Reporting on Covid-19
Publicado: 13/10/2021 -
Are Covid-19 Vaccine Boosters Necessary?
Publicado: 6/10/2021 -
NEJM Interview: Dr. Miguel Hernán on the use of observational data to inform public health and clinical care decisions.
Publicado: 6/10/2021 -
Covid-19 and the Media
Publicado: 29/9/2021 -
Audio of Perspective Roundtable on Race in Medicine
Publicado: 29/9/2021 -
NEJM Interview: Jessica Leston on challenges facing the system that provides health care to American Indians and Alaska Natives.
Publicado: 29/9/2021 -
NEJM Interview: Prof. Michelle Mello on legal cases related to Covid-19 emergency orders and the future of public health law.
Publicado: 22/9/2021 -
Vaccine Efficacy and Boosters in Covid-19
Publicado: 22/9/2021 -
NEJM Interview: Prof. Erin Fuse Brown on lessons from U.S. states that have enacted public option health plans
Publicado: 15/9/2021 -
New Evidence on SARS-CoV-2 Vaccine Boosters
Publicado: 15/9/2021 -
NEJM Interview: Dr. Garth Rapeport on the development and implementation of a SARS-CoV-2 human challenge research program.
Publicado: 8/9/2021 -
Protecting against Severe Disease and Transmission
Publicado: 8/9/2021 -
A New Round of Rising Covid-19 Numbers
Publicado: 1/9/2021 -
NEJM Interview: Dr. Octavio Gómez-Dantés on translating the concept of human rights into health benefits for populations.
Publicado: 1/9/2021 -
NEJM Interview: Dr. Gil Rabinovici on the FDA’s controversial approval of a new treatment for Alzheimer’s disease.
Publicado: 25/8/2021
Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
